NL-OMON50242
Recruiting
Phase 3
eoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer - SANO trial: *Surgery As Needed for Oesophageal cancer*
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- carcinoma of the oesophagus
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 738
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who are planned to undergo or who recently underwent neoadjuvant
- •chemoradiotherapy according to CROSS, followed by surgical resection for
- •histologically proven oesophageal squamous cell carcinoma or adenocarcinoma of
- •the oesophagus or oesophago\-gastric junction;, Age \>\=18;, Written, voluntary,
- •informed consent.
Exclusion Criteria
- •Language difficulty, dementia or altered mental status prohibiting the
- •understanding and giving of informed consent and to complete quality of life
- •questionnaires;, Non\-FDG\-avid tumour at baseline PET\-CT scan.
- •Previous treatment with endoscopic resection.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
eoadjuvant chemoradiotherapy plus surgery versus active surveillance for oesophageal cancer<p>Oesophageal cancer, oesofaguscarcinoom, esophageal cancer, active surveillance</p>10017998NL-OMON25016Erasmus MC300
Recruiting
Phase 3
Cancer injection before surgery vs after surgery in stomach cancerHealth Condition 1: C16- Malignant neoplasm of stomachCTRI/2021/01/030183Jawaharlal Institute of Postgraduate Medical Education and Reserach
Active, Not Recruiting
Phase 1
Chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastasesThe CHARISMA randomized multicenter clinical trialEUCTR2013-004952-39-NLErasmus MC Cancer Institute224
Completed
Phase 3
eo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases ;The CHARISMA randomized multicenter clinical trialLiver metastases colorectal cancer1001981510017998NL-OMON44796Erasmus MC, Universitair Medisch Centrum Rotterdam224
Not Yet Recruiting
N/A
Chemotherapy followed by versus surgery alone in high-risk patients with colorectal liver metastasesColorectal liver metastases, clinical risk score, high risk patients, colorectale levermetastasen, klinische risico score, hoog risico patientenNL-OMON27498Prof. Dr. C. VerhoefErasmus MC Cancer Institute224